The real, EUR-normalised cost of stem-cell / regenerative therapy — by condition and by country — benchmarked against the EU's lowest-cost destination, Bulgaria (€3,000–8,000). Sortable, sourced, free to cite.
Direct answer: across published 2026 pricing, stem-cell therapy runs roughly €2,000–92,000 worldwide depending on condition and country; the EU benchmark at our partner Stem Plus (Sofia) is €3,000–8,000 — typically 60–80% below US, UK and Western-European pricing at full EU GMP standards.
| Condition | EU benchmark · Bulgaria | Global market range | Global midpoint | Registered trials |
|---|---|---|---|---|
| Trouble du Spectre de l'Autisme | €3,000–8,000 | €6,440–€92,000 | €49,220 | 26 |
| Diabète (Type 1 & 2) | €3,000–8,000 | €6,440–€59,800 | €33,120 | 236 |
| Sclérose en Plaques | €3,000–8,000 | €4,140–€92,000 | €48,070 | 92 |
| Maladie de Parkinson | €3,000–8,000 | €3,348–€32,200 | €17,774 | 69 |
| Maladie d'Alzheimer | €3,000–8,000 | €18,900–€21,000 | €19,950 | 41 |
| Paralysie Cérébrale | €3,000–8,000 | €6,000–€7,650 | €6,825 | 41 |
| Atrophie Musculaire Spinale | €3,000–8,000 | €15,000–€30,000 | €22,500 | 5 |
| Dystrophie Musculaire | €3,000–8,000 | €15,000–€30,000 | €22,500 | 26 |
| Polyarthrite Rhumatoïde | €3,000–8,000 | €9,200–€23,000 | €16,100 | 43 |
| Cirrhose Hépatique | €3,000–8,000 | €19,300–€24,000 | €21,650 | 89 |
| Anémie | €3,000–8,000 | €5,000–€25,000 | €15,000 | 531 |
| Hypertension Artérielle | €3,000–8,000 | €5,000–€25,000 | €15,000 | 35 |
| Dysfonction Érectile | €3,000–8,000 | €20,100–€23,400 | €21,750 | 35 |
| Infertilité Masculine | €3,000–8,000 | €7,000–€25,000 | €16,000 | 15 |
| Immunodéficience Primitive | €3,000–8,000 | €19,000–€24,000 | €21,500 | 91 |
| Esthétique et Anti-âge | €3,000–8,000 | €4,600–€13,800 | €9,200 | 9 |
| Retard du Développement Cognitif | €3,000–8,000 | — | — | 2 |
| Arthrose du Genou | €3,000–8,000 | €2,760–€9,200 | €5,980 | 166 |
| Dégénérescence Discale et Vertébrale | €3,000–8,000 | €4,600–€13,800 | €9,200 | 35 |
| Neuropathie Périphérique | €3,000–8,000 | €2,300–€4,600 | €3,450 | 46 |
| Rétablissement suite à un AVC | €3,000–8,000 | €18,400–€27,600 | €23,000 | 108 |
| MPOC et Maladies Pulmonaires | €3,000–8,000 | €16,560–€23,000 | €19,780 | 34 |
| Maladie de Crohn et MICI | €3,000–8,000 | €20,000–€27,500 | €23,750 | 89 |
| Lupus (SLE) | €3,000–8,000 | €9,200–€23,000 | €16,100 | 47 |
| Maladie Rénale Chronique | €3,000–8,000 | €15,000–€30,000 | €22,500 | 88 |
| Perte de Cheveux et Restauration Capillaire | €3,000–8,000 | €1,840–€5,520 | €3,680 | 16 |
| Long COVID | €3,000–8,000 | €2,700–€23,000 | €12,850 | 11 |
| Lésion de la Moelle Épinière | €3,000–8,000 | €23,000–€36,800 | €29,900 | 69 |
| Insuffisance Cardiaque et Réparation Cardiaque | €3,000–8,000 | €18,400–€46,000 | €32,200 | 124 |
| SLA (Sclérose Latérale Amyotrophique) | €3,000–8,000 | €19,100–€24,000 | €21,550 | 65 |
| Psoriasis | €3,000–8,000 | €9,200–€23,000 | €16,100 | 11 |
| Ostéoporose et Santé Osseuse | €3,000–8,000 | €4,600–€7,350 | €5,975 | 14 |
| Lésions Tendineuses et Blessures Sportives | €3,000–8,000 | €3,680–€9,200 | €6,440 | 22 |
| Plaies et Ulcères Chroniques | €3,000–8,000 | €5,000–€15,000 | €10,000 | 59 |
| Dégénérescence Maculaire et Vision | €3,000–8,000 | €9,200–€27,600 | €18,400 | 44 |
| Fibromyalgie et Syndrome de Fatigue Chronique | €3,000–8,000 | €5,000–€25,000 | €15,000 | 1 |
| Arthrose de la Hanche | €3,000–8,000 | €4,600–€9,200 | €6,900 | 12 |
| Sclérodermie (Sclérose Systémique) | €3,000–8,000 | €20,000–€27,500 | €23,750 | 42 |
| Insuffisance Ovarienne Prématurée | €3,000–8,000 | €6,440–€23,000 | €14,720 | 35 |
| Ménopause et Santé Hormonale | €3,000–8,000 | €6,440–€23,000 | €14,720 | 10 |
| Syndrome Douloureux Régional Complexe | €3,000–8,000 | €5,000–€25,000 | €15,000 | 2 |
| Colite Ulcéreuse | €3,000–8,000 | €20,000–€27,500 | €23,750 | 14 |
| Country | Typical treatment range | Source |
|---|---|---|
| Japon | €13,800–€55,200 | cellgrandclinic.com |
| Royaume-Uni | €4,640–€46,400 | bookimed.com |
| États-Unis | €18,400–€46,000 | bioinformant.com, dvcstem.com |
| Allemagne | €6,900–€46,000 | germanyhealth.de |
| Panama | €14,500–€36,800 | cellmedicine.com |
| Corée du Sud | €2,024–€32,200 | koreaclinicguide.com |
| Serbie | €6,500–€31,000 | startstemcells.com |
| Suisse | €3,220–€19,432 | swissmedexpert.com |
| Turquie | €1,840–€18,400 | int.livhospital.com |
| Mexique | €3,220–€13,800 | bookimed.com |
| Colombie | €5,060–€12,880 | bookimed.com |
| Espagne | €3,864–€12,880 | bookimed.com |
| Émirats Arabes Unis | €5,336–€9,936 | theaeonclinic.com |
| Bulgarie | €3,000–€8,000 | placidway.com, startstemcells.com |
| Thaïlande | €1,656–€6,900 | zenifybkk.com |
| Ukraine | €3,680–€5,980 | bookimed.com |
| Inde | €2,300–€5,520 | stemcellcareindia.com |
Figures are indicative, compiled from published clinic and medical-tourism pricing and EUR-normalised (1 USD ≈ 0.92 EUR, 2026-06). Condition figures reflect global market ranges; the EU benchmark is the partner-clinic published range. Use the full-cost calculator for your personal all-in total. Licensed CC BY 4.0 — cite as "StemCellAtlas 2026 Cost Index".
Interactive cost-by-country charts → · Treatment options by condition →
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite